Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Effect of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in Urinary Albumin to Creatinine Ratio in Patients With Overt Kidney Disease

NCT02048904 is registered in ClinicalTrials.gov with University of Missouri-Columbia as lead sponsor.

NCT NCT02048904
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02048904 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Effect of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in Urinary Albumin to Creatinine Ratio in Patients With Overt Kidney Disease
Lead sponsor
University of Missouri-Columbia
Phase
Phase 4
Overall status
Terminated
Start date
January 31, 2014
Completion date
June 30, 2016
Enrollment
142 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

microalbuminuria, type 2 diabetes